Investorideas.com newswire, breaking news for marijuana, cannabis and hemp stocks

Friday, 26 February 2021

Investor Ideas #Potcasts 536, #Cannabis News and #Stocks on the Move; (CSE: $DELC.C) (OTCQB: $DELCF), (TSX: $CWEB.TO) (TSXV: $N.V)

 


Investor Ideas #Potcasts 536, #Cannabis News and #Stocks on the Move; (CSE: $DELC.C) (OTCQB: $DELCF), (TSX: $CWEB.TO) (TSXV: $N.V)

 

Delta, Kelowna, BC, February 26, 2021 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca  release today’s podcast edition of  cannabis news and stocks to watch plus insight from thought leaders and experts.

 

Listen to the podcast:

https://www.investorideas.com/Audio/Podcasts/2021/022621-StocksToWatch.mp3

 

Read this in full at https://www.investorideas.com/news/2021/cannabis-potcasts/02261DELC-DELCF-CWEB-N.asp

 

Hear the investor ideas potcast on Spotify

 

Hear Investor ideas cannabis potcast on iTunes  

 

Today’s podcast overview/transcript:

 

Good afternoon and welcome to another episode of Investorideas.com "Potcast" featuring cannabis news, stocks to watch as well as insights from thought leaders and experts.

 

In today’s podcast we look at a few public company announcements.

 

Delic Holdings Inc. (CSE: DELC) (OTCQB: DELCF), a psychedelic wellness-focused company, announced that it has executed a definitive share purchase agreement to acquire all of the issued and outstanding shares in the capital of Complex Biotech Discovery Ventures ("CBDV"), a licensed psilocybin and cannabis research laboratory focused on extraction, analytical testing, and chemical process development. Founded by award-winning chemist, Dr. Markus Roggen, and UBC Professor, Glenn Sammis, CBDV supports the psychedelic industry with high precision chemical analytics and metabolomic identification. Following the Transaction, CBDV expects to change its name to "DELIC Labs".

 

Transaction Highlights

       The acquisition of CBDV will further establish DELIC as a diversified psychedelics organization: The addition of CBDV will allow DELIC to add scientific-based research and analytics to its product offerings. CBDV recently received its Section 56 Exemption granted by Health Canada, enabling CBDV to focus on research and intellectual property development with psilocybin.

       Building an Intellectual Property ("IP") portfolio: CBDV plans to use its analytical tools for psychedelic mushroom compounds that advance clinical and end-user testing. Development of psilocybin analogs that could be used in future medical treatments.

       Enhanced exposure of CBDV to drive growth: DELIC expects to drive customers to CBDV through its media platform, allowing CBDV to expand its current customer base and potential product offerings.

       History of profitability: CBDV has a history of profitability, with a focus on extraction optimization, analytical testing, and chemical process development to advance the cannabis and psilocybin industry. Current and past customers are well-established global enterprises who require the cutting-edge cannabis and soon, psilocybin research, which CBDV provides services to.

       Management expertise. Dr. Roggen, who will remain as an employee of CBDV following closing of the Transaction, brings a wealth of knowledge and industry experience to DELIC, in a critically important and evolving space.

 

Matt Stang, Founder and CEO of DELIC, commented, "Joining forces with CBDV is a foundational transaction for DELIC. Science and research is the backbone of the psychedelic renaissance and adding the talent, know-how and expertise of CBDV will bear fruit both now and in the years to come. The fact that the company has a world-class team, history of profitability, more than 50 blue chip clients, and is on track for significant growth, makes this a compelling acquisition for DELIC and one that makes it a pillar of the Company. Going forward, with the discussions we currently have in place with the many entrepreneurs worldwide within the DELIC ecosystem, we see an opportunity to potentially commercialize this science in the near term."

 

CBDV is one of a handful of licensed research psilocybin labs in Canada and has an aggressive plan to build out a suite of novel compounds and delivery methods for the industry. The company is also a leading cannabis analytical and research company boasting clients that include some of the largest brands in the world. CBDV intends to apply for its dealer's license, to eventually commercialize its psilocybin research and associated IP.

Dr. Roggen, CEO of CBDV, stated "This is a very exciting moment for us at CBDV. Partnering with DELIC was an easy choice. The combination will allow us to use their platform to share our findings with the psychedelic and medical community while also gaining new clients on the cannabis front. It's a great opportunity to work in tandem with the DELIC team to help these new age treatments become accessible for all."

 

Matt Stang continues, "The DELIC ecosystem will benefit greatly from the IP that will come out of CBDV. As new jurisdictions start to decriminalize and legalize psilocybin, we feel we will have the IP that everyone will want. On top of that, our roots in cannabis are deep and we feel we can direct significant revenue in our network towards CBDV's cannabis business." 

 

Charlotte's Web Holdings, Inc. (TSX: CWEB) (OTCQX: CWBHF), the market leader in hemp CBD wellness products, today announced a long-term scientific collaboration between McLean Hospital, a Harvard Medical School affiliate, and the Company.  Funding and product support are provided by the CW Labs division of Charlotte's Web Inc.

 

Two distinct clinical trials will be overseen by lead researcher/investigator Dr. Staci A. Gruber, Ph. D, Associate Professor of Psychiatry at Harvard Medical School and Director of the MIND program at McLean Hospital in Belmont, Mass.  These two studies will investigate the efficacy of a custom-formulated, hemp-derived high-CBD product. Clinical trial results are to be published in 2022. Dr. Gruber is also conducting a number of other studies, including a longitudinal observational study of Veterans who use a Charlotte's Web product.

 

Dr. Gruber's Marijuana Investigations for Neuroscientific Discovery (MIND) Program, established in 2014, is the first of its kind, and is dedicated to studying the long-term impact of cannabis and cannabinoids for medical and adult use which utilizes various clinical and cognitive tools as well as multimodal neuroimaging techniques.

 

"We are honored to be working with Dr. Gruber, Harvard Medical School and McLean Hospital on these important clinical trials," said Tim Orr, President of Charlotte's Web's CW Labs divison. "Charlotte's Web remains dedicated to supporting third-party research on hemp CBD investigated by some of the country's top scientists."

 

Namaste Technologies Inc. (TSXV: N) (OTC: NXTTF) a marketplace platform for cannabis and wellness products, announced that www.CannMart.com is live in the USA offering Americans hemp derived CBD and smoking accessories. Namaste is excited to be leveraging its VendorLink technology in collaboration initially with DankStop and PeakBirch Logic, Inc., and looks forward to adding more partners to the platform.

 

The announcement of this expansion in the USA underscores Namaste’s intention to increase its total addressable market and exploration into other verticals and geographies as regulation evolves and other adjacent complementary market opportunities present themselves.

 

“With ever stronger signals that the regulatory landscape in the USA is evolving, our entry into the jurisdiction through the sale of hemp derived CBD and accessories will position us strategically to begin capturing new market share and build a first mover advantage if and when cannabis becomes legalized federally,” said Meni Morim, CEO of Namaste. “This development also further validates our investment in technology, as the expansion will be facilitated via our marketplace technology. We look forward to building on this positive momentum as we continue to execute our strategy to position Namaste as a leading global cannabis and wellness company.”

 

“Our goal will be to aggressively expand our footprint into the USA as we scale up our marketplace platform,” said Chad Agate, CTO and VP of Marketplace at Namaste. “We are not growing or exporting products from Canada into the USA, we are simply carving out our role as the facilitators using CannMart.com and our VendorLink platform. American and other companies that wish to sell legal products in the USA can now use our innovative platform to conduct business similarly to Amazon. We look forward to adding more partners selling their innovative products throughout the USA.”

 

Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) today announced its 2020 fourth quarter and full-year business results.

“Our fourth quarter 2020 results are the summation of the hard work and perseverance the Company has put into this past year despite the challenges of 2020. As we look to 2021, I’m incredibly excited about the teams we have supporting our brands and the breakthrough research and development ("R&D"), innovation and exciting marketing campaigns Cronos Group plans to execute on. We are poised to build upon the growth we experienced in 2020 as we continue to push cannabinoid innovation and differentiated product offerings under our portfolio of brands,” said Kurt Schmidt, President and CEO of Cronos Group. “My goals this year will be to focus on building a winning team by fostering a collaborative, performance-driven culture; continue to focus on creating disruptive technology and innovation; grow and develop our brands and strengthen our ability to compete through R&D, strategic global infrastructure and engaging in the legislative process in key markets.”

Fourth Quarter 2020

      Net revenue of $17.0 million in Q4 2020 increased by $9.7 million from Q4 2019. The increase year-over-year was primarily driven by continued growth in the adult-use market in Canada, sales in the Israeli medical market and growth in our U.S. segment. Partially offset by non-recurring wholesale revenue in the Canadian market in Q4 2019 and strategic price reductions on various adult-use cannabis products in Canada in Q4 2020.

      Gross loss of $14.9 million in Q4 2020 decreased by $5.2 million from Q4 2019. The decrease in losses year-over-year was primarily driven by a decline in inventory write-downs and increased gross profit in the U.S. segment. Offset by third party purchased flower associated with adult-use products in Canada and a decline in wholesale sales in Q4 2020 versus Q4 2019.

      The Company incurred an inventory write-down in Q4 2020 of $15.0 million on dried cannabis and cannabis extracts, primarily driven by cannabis product price compression in the Canadian market. The Company may incur further inventory write-downs due to pricing pressures in the marketplace.

      Adjusted EBITDA loss of $53.1 million in Q4 2020 increased by $1.5 million from Q4 2019. The increase in losses year-over-year was primarily driven by an increase in general and administrative expenses and an increase in R&D spending.

      Capital expenditures of $11.0 million in Q4 2020 increased by $10.2 million from Q4 2019. The increase year-over-year was primarily driven by spending at the Company's Peace Naturals campus, Cronos Fermentation, our Israeli facility, and our new ERP system.

Full-Year 2020

      Net revenue of $46.7 million in Full-Year 2020 increased by $23.0 million from Full-Year 2019. The increase year-over-year was primarily driven by continued growth in the adult-use market in Canada, growth in our U.S. segment, which included a full-year of the Redwood business as opposed to 117 days in Full-Year 2019, and sales in the Israeli medical market. Partially offset by non-recurring wholesale revenue in the Canadian market in Full-Year 2019 and strategic price reductions on various adult-use cannabis products in Canada in Full-Year 2020.

      Gross loss of $25.8 million in Full-Year 2020 increased by $8.2 million from Full-Year 2019. The increase in losses year-over-year was primarily driven by third party purchased flower associated with adult-use products in Canada and a decline in wholesale sales in Full-Year 2020 versus Full-Year 2019. Partially offset by increased gross profit in the U.S. segment due to a full year of results from the Redwood business and a decrease in inventory write-downs in the ROW segment.

      The Company incurred an inventory write-down in Full-Year 2020 of $26.1 million, on dried cannabis and cannabis extracts, primarily driven by cannabis product price compression in the Canadian market. The Company may incur further inventory write-downs due to pricing pressures in the marketplace.

      Adjusted EBITDA loss of $147.3 million in Full-Year 2020 increased by $48.9 million from Full-Year 2019. The increase in losses year-over-year was primarily driven by an increase in gross loss, increased general and administrative expenses, higher sales and marketing costs related to brand development and R&D spending.

      Capital expenditures of $35.4 million in Full-Year 2020 decreased by $3.6 million from Full-Year 2019. The decrease year-over-year was primarily driven by a reduction in spending at the Company's Peace Naturals campus and Cronos Israel. Partially offset by an increase in spending at Cronos Fermentation.

Investor ideas reminds all listeners to read our disclaimers and disclosures on the Investorideas.com website and that this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment.

 

Learn more about our cannabis podcasts at https://www.investorideas.com/Audio/Potcasts.asp

Or www.potcasts.ca

 

Investors can trade these stocks and other ideas on our site using our  list of top stock trading apps including Robinhood , Acorn, Stash  and others.

To hear more Investorideas.com podcasts visit: https://www.investorideas.com/Audio/.

Investorideas.com podcasts are also available on iTunes,  Spotify, Google Play Music, Stitcher, Spreaker,   YouTube via Spreaker,  iHeartradio and Tunein.

 

Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708

 

About Investorideas.com - News that Inspires Big Investing Ideas

Investorideas.com is a recognized news source publishing third party news, research and original financial content. Learn about investing in stocks and sector trends with our news alerts, articles, podcasts and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy and more. Investor Idea’s original branded content includes the following podcasts and columns : Crypto Corner , Play by Play sports and stock news column, Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast and column,  Cleantech and Climate Change , Exploring Mining  the AI Eye .

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions.

More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com  Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

 

Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.

 

Learn more about sponsoring this podcast or be a guest and our other branded content opportunities at Investorideas.com

 

Follow us on Twitter https://twitter.com/Investorideas

Follow us on Facebook https://www.facebook.com/Investorideas

Follow us on YouTube https://www.youtube.com/c/Investorideas

Download our Mobile App for iPhone and Android 

Join our Investor Club https://www.investorideas.com/membership/

 

Contact Investorideas.com

800 665 0411

 

 

 


Get more Cannabis Stock Investor Ideas – news, articles, podcasts and stock directory


New #Stocks to Watch at Investor Ideas in Crypto (TSX: $EBIT.TO) (TSX: $EBIT.U.TO), (TSX: $BTCC-B.TO) (TSX: $CXI.TO) (OTCBB: $CURN), (OTC: $OBTC)

  New #Stocks to Watch at Investor Ideas in Crypto (TSX: $EBIT.TO) (TSX: $EBIT.U.TO), (TSX: $BTCC-B.TO) (TSX: $CXI.TO) (OTCBB: $CURN), (OTC: $OBTC)

 

 Psychedelics, Tech, eSport, Mining stocks also new at Investor Ideas

 


 

 


 

 

 

 

 

 

 

 

 

Point Roberts WA, Delta BC, February 26, 2021 – (Investorideas.com Newswire) Investorideas.com, a global news source and leading retail investor and trader resource, announces its weekly roundup of stocks to watch in Crypto, Psychedelics, Tech, eSport and Mining. Today’s stocks have been added to our list of free stock directories in each sector.

 

Read this in full at https://www.investorideas.com/news/2021/main/02261Stocks.asp

 

Investors can trade these stocks and other ideas on our site using our list of top stock trading apps including Robinhood, Acorn, Stash and others.

 

New crypto stocks include bitcoin ETFs, a Trust and a fintech company that has expanded into crypto exchange services.

 

The latest psychedelic stocks are involved in psilocybins and mushrooms, tech stocks include cybersecurity.

 

The newest eSport and mining companies are both Canadian listed with operations based in British Columbia.

 

New Stocks added to Crypto Stocks Directory:

Bitcoin ETF (TSX  EBIT) (TSX : EBIT.U) will provide investors with exposure to the daily price movements of the U.S. dollar price of bitcoin by utilizing the benefits of the creation and redemption processes offered by the exchange traded fund structure. Investors in EBIT will directly own bitcoin on the Bitcoin blockchain in a cold wallet. Gemini Trust Company, LLC will act as the Sub-Custodian in respect of EBIT’s holdings of bitcoin.

 

Purpose Bitcoin ETF (TSX:BTCC-B.TO) is held in secure, offline storage, which is also known as “cold” storage because it is not actively connected to the internet. We do use an online or “hot” wallet, but only for transitory purchases when the ETF is buying and selling Bitcoin. The ETF only invests in and holds 100% physically settled Bitcoin.

 

Osprey Bitcoin Trust (OTC: OBTC) offers common sense solutions to digital asset investing. Based in Tarrytown, New York, Osprey is dedicated to building better investment products that offer secure, transparent, and cost-effective access to digital assets. The Osprey Bitcoin Trust, OBTC, is the lowest-cost publicly traded bitcoin-focused investment product in the world.

 

Currency Exchange International,Corp. (TSX:CXI) (OTCBB:CURN) is in the business of providing a range of foreign exchange technology and processing services in North America. Primary products and services include the exchange of foreign currencies, wire transfer payments, Global EFTs, purchase and sale of foreign bank drafts and international travelers’ cheques, and foreign cheque clearing. Related services include the licensing of proprietary FX software applications delivered on its web-based interface, www.ceifx.com (“CEIFX”), and licensing retail foreign currency operations to select companies in agreed locations. The Company’s wholly-owned Canadian subsidiary, Exchange Bank of Canada, based in Toronto, Canada, provides foreign exchange and international payment services in Canada through the use of its proprietary software – www.ebcfx.com.  CRYPTO: Partnered with Cyclebit, a Cryptocurrency Payment Gateway, and CEX.IO, a regulated cryptocurrency exchange, to offer the first concierge service experience for buying cryptocurrencies. Customers can purchase Bitcoin and Ethereum in less than 10 minutes at select CXI branch locations starting February 17, 2021

 

New Stocks added to Psychedelics Stocks Directory:

Halo Collective Inc. (NEO:HALO)(OTC:HCANF) is a leading, vertically integrated cannabis company that cultivates, extracts, manufactures and distributes quality cannabis flower, oils and concentrates, and has sold approximately eight million grams of oils and concentrates since inception. Halo continues to evolve its business and scale efficiently, partnering with trustworthy leaders in the industry, who value the Company's operational expertise in bringing top-tier products to market. Recently, the Company has entered into a non-binding letter of intent with Red Light Holland Corp. for the purpose of creating a joint venture to become a licensed psilocybin manufacturer to supply psilocybin products to licensed service centers in the State of Oregon.

 

Optimi Health Corp. (CSE: OPTI; OPTI.WT) is developing a vertically integrated Canadian functional mushroom brand that focuses on the health and wellness food markets. The Company also intends to cultivate, extract, process and distribute high quality strains of fungi products at its GMP certified facility located in Princeton, British Columbia.

 

New Stocks added to Tech Stocks Directory:

SoLVBL Solutions Inc. (CSE:SOLV) is a cybersecurity company. The company’s mission is to empower, better, faster decisions by developing a universal standard for establishing digital record authenticity. The lead product Q by SoLVBL TM, is a proprietary software of the company, designed to be easy to use and adopt, economically priced and provide digital record authentication at lightning fast speed. Q by SoLVBL TM allows organizations to establish trust in their data. The company is currently pursuing the following verticals: chain of custody for digital evidence; including, next generation 911 (“NG911”), data used in the financial sector, medical applications and critical internet of things (“IoT”) infrastructures.

 

New Stocks added  to eSport Stocks Directory:

TGS Esports Inc. (TSX:TGS.V) works with fortune 500 brands, schools, and tournament organizers to address the esports demographic by building their esports presence and community via tournaments, broadcast production, and events, both live and online. TGS works with some of the biggest brands in the world, including Red Bull, HyperX, Pepsi, Shaw Cable, Telcel, and Ubisoft to expand their reach by delivering unparalleled, all-in-one exports experiences.

 

New Stocks added to Mining Stocks Directory:

Rockland Resources Ltd. (CSE:RKL) is a junior mineral exploration company.  The Issuer is engaged in the business of exploring its principal property, the Summit Old Timer Property, located in British Columbia.

 

The directories are not meant as recommendations but as a research tool to discover opportunities and trading ideas in a particular sector.

 

About Investorideas.com - News that Inspires Big Investing Ideas Investorideas.com is a recognized news source publishing third party news and press releases, research and our own original financial content. We were one of the first retail investor sites to cover renewable energy and cleantech stocks at investorideas.com and our domain Renewableenergystocks.com. We were also one of the most well- known and cited defense stock sites, featuring our domain Homelanddefensestocks.com at its peak.

We follow the money for investors as sector sentiment shifts and technology disrupts. Our mission is to provide investor ideas with breaking news, resources, industry articles and interviews with leading experts.      

 

Learn about investing in stocks and sector trends with our news alerts, articles,  podcasts and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy and more. Investor Idea's original branded content includes the following podcasts and columns: Crypto CornerPlay by Play sports and stock news column, Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast and column, Cleantech and Climate ChangeExploring Mining and the AI Eye.

 

Public companies within the sectors we cover use our news and content services to tell their story to interested investors. Paid for content is disclosed.  

 

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions.

More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com

Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

 

Learn more about our news, PR and social media, podcast and ticker tag services at Investorideas.com

https://www.investorideas.com/Investors/Services.asp

 

Learn more about advertising and guest posts

https://www.investorideas.com/Advertise/

 

Follow us on Twitter https://twitter.com/Investorideas

Follow us on Facebook https://www.facebook.com/Investorideas

Follow us on YouTube https://www.youtube.com/c/Investorideas

Download our Mobile App for iPhone and Android  

 

Join our Investor Club https://www.investorideas.com/membership/

 

Contact Investorideas.com

800 665 0411

 


 


 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Wednesday, 24 February 2021

Investorideas.com - Cannabis Stock News: Australis (CSE: $AUSA.C) (OTC: $AUSAF) Completes Definitive Agreement to Acquire 51% Stake in ALPS

Investorideas.com - Cannabis Stock News: Australis (CSE: $AUSA.C) (OTC: $AUSAF) Completes Definitive Agreement to Acquire 51% Stake in ALPS

Investorideas.com - Cannabis Stock News: Australis (CSE: $AUSA.C) (OTC: $AUSAF) Completes Definitive Agreement to Acquire 51% Stake in ALPS

Investorideas.com - Cannabis Stock News: Australis (CSE: $AUSA.C) (OTC: $AUSAF) Completes Definitive Agreement to Acquire 51% Stake in ALPS

Investorideas.com - Cannabis Deal Tracker: Investment and M&A Activity in the Cannabis Industry February 15th - February 19th, 2021

Investorideas.com - Cannabis Deal Tracker: Investment and M&A Activity in the Cannabis Industry February 15th - February 19th, 2021

Investor Ideas #Potcasts 535, #Cannabis News and #Stocks on the Move; (NEO: MGW) (OTCQB: $MGWFF) (TSX: $APHA.TO) (NASDAQ: $APHA) (NASDAQ: $TLRY) (CSE: $AUSA.C)

 


Investor Ideas #Potcasts 535, #Cannabis News and #Stocks on the Move; (NEO: MGW) (OTCQB: $MGWFF) (TSX: $APHA.TO) (NASDAQ: $APHA) (NASDAQ: $TLRY) (CSE: $AUSA.C)

 

Delta, Kelowna, BC, February 24, 2021 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca  release today’s podcast edition of  cannabis news and stocks to watch plus insight from thought leaders and experts.

 

Listen to the podcast:

https://www.investorideas.com/Audio/Podcasts/2021/022421-StocksToWatch.mp3

 

Read this in full at  https://www.investorideas.com/news/2021/cannabis-potcasts/02241MGWFF-APHA-TLRY-AUSA.asp

 

Hear the investor ideas potcast on Spotify

 

Hear Investor ideas cannabis potcast on iTunes  

 

Today’s podcast overview/transcript:

 

Good afternoon and welcome to another episode of Investorideas.com "Potcast" featuring cannabis news, stocks to watch as well as insights from thought leaders and experts.

 

In today’s podcast we look at a few public and private company announcements.

 

Everest BioPharma International Inc.  announced that it has received, in February  2021, its notification of Eligible Business corporation ("EBC") under the BC Venture Capital Act  allowing BC investors a 30% Tax Credit. The Company is presently completing the internal build-out of its state-of-the art cannabis extraction systems in Kelowna, BC. The first sales of live rosen and its derivatives are expected in May, 2021.

 

Everest is installing large capacity ice water bubble hash solventless processing equipment with ancillary rosen presses, which also allows the ability for "organic" registration, adding further value to its products.

 

Nigel Boast, President and CEO of Everest BioPharma stated; "Our  registration  as an eligible business corporation "EBC" in BC (attracting a 30% tax credit) will facilitate funding required for us to fully implement our business plan which firstly focuses on tolling service fees and then the sale of our proprietary medical CBD products. Two recent standard processing license sales: Premium 5 with a similar business model ($40M), and LYF Food ($43M) indicate a high valuation for Everest.

 

Rob Hatch, COO of Everest BioPharma stated; "By processing from frozen, we save our tolling customers time and money because there is no requirement to trim and dry the product. There are approximately 147 standard cultivation licenses in Canada without extraction licenses."

 

Aphria Inc. (TSX: APHA) (NASDAQ: APHA), a leading global cannabis-lifestyle consumer packaged goods company inspiring and empowering the worldwide community to live their very best life, and Tilray, Inc. (NASDAQ: TLRY), a global pioneer in cannabis research, cultivation, production and distribution, announced the launch of the website: www.aphriatilraytogether.com. This new, dedicated resource seeks to provide  shareholders of both companies with pertinent information, news and updates leading up to the special meetings of shareholders at which Aphria's and Tilray's respective shareholders will vote on the resolutions necessary to implement the proposed business combination of the two companies.  The website will also allow shareholders and other interested parties to register for Transaction updates that are made publicly available, so they receive information directly to their e-mail addresses.

 

As disclosed in the preliminary joint proxy statement and management information circular filed with regulators on February 19, 2021, both companies are pleased that the applicable waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, has expired in relation to the Transaction.  In addition, the companies have received a no-action letter from the Competition Bureau of Canada in respect of the Transaction, which confirms that the Competition Bureau does not intend to challenge the Transaction under the Competition Act (Canada).  The receipt of the HSR Clearance and the Competition Act Approval are two of the required regulatory clearances that need to be obtained to satisfy the conditions to closing of the Transaction. The closing of the Transaction is currently expected to occur in the second quarter of calendar year 2021.

 

Irwin D. Simon, Aphria's Chairman and Chief Executive Officer commented, "The receipt of HSR Clearance and Competition Act Approval represent a significant step forward in bringing together these two companies, and we are incredibly pleased that we remain on track to complete our business combination in the second quarter of calendar year 2021.  Together, Aphria and Tilray expect to have a robust strategic footprint in Canada and internationally with the operational scale necessary to compete more effectively in today's consolidating cannabis market. We believe our strong, flexible balance sheet, cash position and access to capital will provide us with the ability to accelerate long-term sustainable growth and deliver attractive returns for shareholders."

 

Australis Capital Inc. (CSE: AUSA) (OTC: AUSAF) announced today that, further to its press release dated January 5, 2021, the Company has entered into a definitive agreement with the principals of ALPS for the acquisition of 51% of the issued and outstanding shares in ALPS. The Definitive Agreement has an option permitting the Company to acquire the remaining 49%. Furthermore, the ALPS Transaction also includes the appointment of Terry Booth as AUSA's CEO upon completion.

 

 

Since its management buyout from Aurora Cannabis in May 2020, ALPS has rapidly built a blue-chip roster of global customers and a growing pipeline of potential new deals. ALPS currently is executing on a number of contracts, including four that were signed and announced in the past month:

       Aurora Cannabis - Annual ongoing services contract, multiple locations globally

       Cann Group - Cannabis facility contract + APIS extended services contract in Australia

       Multiple undisclosed cannabis related contracts in the U.S.

       Bluehouse Greenhouse – 62 acre vegetable facility contract in California, U.S.

       Vertical Harvest – 200,000 sqft multi-level urban facility contract in Wyoming, U.S.

       Aldershot Greenhouses – 200,000 sqft facility expansion contract in Ontario, Canada

       200,000 sqft small plant production facility in Finland

       20,000 sqft crop research facility in northern U.S.

       Tropica – facility for the cultivation of aquarium plants in Germany

       McMaster University, life Science Centre, Ontario, Canada

       Queen, Denmark – ornamental plants

       Middle East – large fruit & vegetable facility

 

The ALPS Transaction, upon closing, will be immediately accretive to AUSA results, with further material growth anticipated in the coming months.

 

Maple Leaf Green World Inc. (NEO: MGW) (OTCQB: MGWFF) announced that it has signed an agreement with Hempacco Co. Inc., a vertically integrated California-based Hemp CBD, CBG R&D, marketing, and manufacturing company, to develop, manufacture and market its new brand of CBG Hemp cigarettes.

 

The Agreement aims to develop a new CBG hemp cigarette brand for Maple Leaf using their California-grown hemp. Hempacco will handle all of the research, development, and manufacturing of a retail-ready 20-pack CBG-rich hemp cigarette brand.

 

"I’m excited to work with Hempacco to develop our brand of CBG hemp cigarettes; this is a pivot for our company after identifying the growing hemp cigarette space and the market opportunity not only in the USA, but also in Canada and internationally”, said Raymond Lai, CEO of Maple Leaf, “Our CBG farm is minutes away from Hempacco’s manufacturing location, which makes it an amazing opportunity to have our own seed to shelve product and deliver an incredible hemp smokable quality experience to the consumer,” Raymond concluded.

 

“It’s been a pleasure working with Raymond and his team to launch Maple Leaf’s new CBG brand in our quest to disrupt Tobacco™,” said Sandro Piancone, CEO of Hempacco. “We’re committed to a fast launch of the CBG hemp cigarette brand and following it up with an eCommerce portal that integrates picking, packing, and shipping all from one location close to the Maple Leaf’s farm,” Sandro concluded.

 

The hemp cigarette private label manufacturing agreement is for five (5) years consists of two (2) phases. The first phase is hemp cigarette product development, including Research & Development, Business Modelling, and hemp cigarette white label Manufacturing sub-phases. Hempacco will undertake all the necessary work for the three (3) sub-phases, including packaging and shipping, where Maple Leaf supplies raw hemp material. Maple Leaf and Hempacco will jointly develop branding and packaging artwork that Hempacco will manufacture. The second phase is to establish an e-commerce Strategy, which will expand Maple Leaf’s online and social media presence by developing a full e-commerce platform. Through the Company’s new hemp cigarette online store, CBG hemp cigarettes, packaged flower jars, and subsequent product developments will be available for purchase and shipped across the United States and Overseas. Both phases will commence immediately.

 

Hempacco will invest in the brand by paying for all the initial start-up costs associated with both phases. Maple Leaf will contribute to the manufacturing and order processing cost when sales are made. As compensation for Hempacco’s services, Maple Leaf will pay Hempacco two (2) million common shares at $0.075 per share for phase 1 and one (1) million common shares at $0.075 per share for phase 2 provided that both phases are completed within 45 days after the agreement date and accepted by Maple Leaf. The issuance of three (3) million common shares is subject to Maple Leaf’s Broad of Directors and Neo Stock Exchange's approval.

 

The Agreement will leverage Hempacco’s fully integrated supply chain to manufacture, package, market, and distribute Maple Leaf’s CBG Hemp Cigarettes as well as leveraging Maple Leaf’s digital branding artwork, expertise in cultivating high quality, organic CBG Hemp, and its role as a gateway for penetrating international markets. By utilizing the resources from both Maple Leaf and Hempacco, the Agreement will disrupt the cigarette industry by providing a naturally great-tasting alternative to traditional tobacco and nicotine cigarettes. Hemp cigarettes are also a great alternative to marijuana by offering the non-psychoactive effects caused by THC with the added benefits of CBG.

 

Investors can trade these stocks and other ideas on our site using our  list of top stock trading apps including Robinhood , Acorn, Stash  and others.

Investor ideas reminds all listeners to read our disclaimers and disclosures on the Investorideas.com website and that this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment.

 

Learn more about our cannabis podcasts at https://www.investorideas.com/Audio/Potcasts.asp

Or www.potcasts.ca

 

Hear the investor ideas potcast on Spotify

To hear more Investorideas.com podcasts visit: https://www.investorideas.com/Audio/.

Investorideas.com podcasts are also available on iTunes,  Spotify, Google Play Music, Stitcher, Spreaker,   YouTube via Spreaker,  iHeartradio and Tunein.

 

Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708

 

About Investorideas.com - News that Inspires Big Investing Ideas

Investorideas.com is a recognized news source publishing third party news, research and original financial content. Learn about investing in stocks and sector trends with our news alerts, articles, podcasts and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy and more. Investor Idea’s original branded content includes the following podcasts and columns : Crypto Corner , Play by Play sports and stock news column, Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast and column,  Cleantech and Climate Change , Exploring Mining  the AI Eye .

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com

Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy:

https://www.investorideas.com/About/Private_Policy.asp

 

Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.

 

Learn more about sponsoring this podcast or be a guest and our other branded content opportunities at Investorideas.com

 

Follow us on Twitter https://twitter.com/Investorideas

Follow us on Facebook https://www.facebook.com/Investorideas

Follow us on YouTube https://www.youtube.com/c/Investorideas

Download our Mobile App for iPhone and Android 

Join our Investor Club https://www.investorideas.com/membership/

 

Contact Investorideas.com

800 665 0411

 

 

 


Get more Cannabis Stock Investor Ideas – news, articles, podcasts and stock directory


House Advances SAFE Banking Act as Part of the Must-Pass NDAA

House Advances SAFE Banking Act as Part of the Must-Pass NDAA